In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 129 for your search:
Drug:  vorinostat
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 3 to 21
Sponsor: NCI
Protocol IDs: NCI-2011-02616, CDR0000688443, ACNS0822, U10CA098543, COG-ACNS0822, NCT01236560

2.

Phase: Phase III, Phase II
Type: Tissue collection/Repository, Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-00242, SWOG-S1117, CDR0000723909, S1117, U10CA032102, U10CA180888, NCT01522976

3.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MK-0683-014, 2005_010, NCT00128102

4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: NCI-06-C-0040, MERCK-014-01, NCI-P6690, NCT00265577, UCLA-0506053-01, MERCK-014-00

5.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 0683-088, 2008_525, NCT00773747

6.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00093, NA 00001107, NCI-6884, JHOC-J0570, CDR0000467800, 6884, JHOC-00001107, J0570, IRB #NA 00001107, SKCCC J0570, U01CA070095, U01CA062491, NCT00324870

7.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 21 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00095, NYWCCC-0511008257, CDR0000472916, NCI-6896, 0511008257, 6896, N01CM62204, P30CA013330, NCT00324740

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03012, 06-05-291, 7703, N01CM62204, N01CM62207, N01CM62205, N01CM62209, AECM-0605291, NCI-7703, NCT00368875

9.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-01050, CDR0000511887, NYCC-6898, NCI-6898, 11-1773, 6898, N01CM17103, N01CM62204, P30CA013330, NCT00392353

10.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: BR05/24/06, DSRB Reference Code: B/06/275, HSA No: CTC0600314, NCT00416130

11.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-0709, NCI-2010-00782, 4808704, NCT00555399

12.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: PSOC 2302, NCI-2010-00870, 6632, FHCRC-IR-6632, NCT00601718

13.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Other
Protocol IDs: 08-045, NCT00667615

14.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: PSHCI 08-005, NCT00702962

15.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00672, CDR0000609743, ABTC 0902, N0874, U10CA180821, U10CA025224, NCCTG-N0874, NCT00731731

16.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 to 85
Sponsor: NCI, Other
Protocol IDs: CDR0000615128, P30CA069533, OHSU-4180, HEM-08002-L, MERCK-OHSU-4180, 4180, OHSU-HEM-08002-L, NCT00764517

17.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: GFM VOR 2007-01, NCT00776503

18.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2008-0484, NCT00787527

19.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UMCC 2008.095, NCT00810602

20.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 50 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01147, IR-6921, CDR0000642213, 2288.00, 8297, P30CA015704, FHCRC-2288.00, NCT00895934

21.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: PSOC 2401, NCI-2010-00324, IR-6956, MERCK-PSOC-2401, NCT00918723

22.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: Pro00016446, NCT00939991

23.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 09-114, NCT00948688

24.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01964, CDR0000653803, S0806, U10CA032102, SWOG-S0806, NCT00972478

25.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: NCCCTS-09-433, NCT01027676
1     
New Search